Rajendra (Raj) K Pandey

Rajendra (Raj) K Pandey has worked in the pharmaceutical industry for over 19 years. In 2021, they took on the role of Vice President of Chemistry at Cargene Therapeutics. From 2018 to 2021, Raj was the Senior Director/Director of Oligonucleotide Chemistry at Aligos Therapeutics. From 2015 to 2018, they were the Scientific Director of the Oligo CoE at Janssen R&D Pharmaceutical Companies of Johnson & Johnson. From 2011 to 2015, Raj was the Group Leader of Nucleic Acids Therapeutics at Spring Bank Pharmaceuticals, Inc. From 2010 to 2011, they were the Principal Scientist of Oligo Chemistry at Girindus America Inc. Member of the Solvay Group. From 2003 to 2010, Raj was the Senior Scientist/Scientist at Alnylam Pharmaceuticals. Finally, from 2002 to 2003, they were a Scientist at Hybridon Inc.

Rajendra (Raj) K Pandey began their education in 1993, when they earned their Ph D in Nucleic Acids Chemistry from the University of Allahabad. Rajendra (Raj) K then went on to the University of Ulm, Germany, where they completed a Post-Doc in Nucleic Acids Chemistry from 1998 to 2000.